The Canadian tech company, BlackBerry Ltd (NASDAQ:BBRY) sent a slew of executives to CES this week to reassure the public about its prospects and to promote its latest products. But unlike last year, when execs proudly showed off BlackBerry 10 smartphones at the consumer electronics trade show, the focus this year was more on the software side. BlackBerry Ltd (NASDAQ:BBRY) stock opened at $8.65 in last trading session and closed at $8.72. The 52 week range of the stock is $5.44 – $18.32 and the day range was $8.42 – $8.74.
Research analysts at FBR Capital Markets lifted their price objective on shares of 3D Systems Corp. (NYSE:DDD) from $85.00 to $98.00 in a report released on Friday, StockRatingsNetwork.com reports. The firm currently has an “outperform” rating on the stock. FBR Capital Markets’ target price indicates a potential upside of 2.04% from the company’s current price. 3D Systems Corporation (NYSE:DDD) stock opened at $96.47 in current trading session, and trading at $94.41, trading in the range of $94.31 – $96.55. The stock showed a positive weekly performance of 1.96%.
Athersys, Inc. (NASDAQ:ATHX) has announced today that it has entered into definitive agreements to sell 5,000,000 shares of common stock and warrants to purchase up to 1,500,000 shares of common stock, in an offering with gross proceeds of approximately $20.5 million. All of the participants in the offering are current shareholders of the company. The warrants are immediately exercisable. The warrants have an exercise price of $4.50 per share of common stock and expire on July 15, 2016. Each share of common stock, along with a warrant to purchase up to 0.30 shares of common stock, was offered for a purchase price of $4.10. Athersys, Inc. (NASDAQ:ATHX) shares trading at $4.03 on current trade day, by losing -0.49%. Stock 52 week range is $1.12 – $4.33. Company’s market capitalization is $283.51 billion.
GlaxoSmithKline plc (ADR) (NYSE:GSK) gains accelerated FDA approval for combination use of Mekinist and Tafinlar GlaxoSmithKline plc (ADR) (NYSE:GSK) stock decreased -0.32% with current price of $52.70. The EPS of the stock remained 2.64. Company’s market capitalization is $129.28 billion.